GENE THERAPY READY
Live / Registered — Registered (as of 20 Dec 2022)
What this means for you
Registered since 20 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90673637
- Registration number
- 6927368
- Mark type
- Stylized text
- Filed
- 27 Apr 2021
- Published for opposition
- 04 Oct 2022
- Registered
- 20 Dec 2022
- Attorney of record
- Andrew J. Ferren
Goods and services
- Class 035 — Advertising and business services: organizing and administering a network of research sites, namely, business management in the field of clinical trials, specifically, providing governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes
- Class 042 — Scientific and technological services: Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, evaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, testing, analysis, and evaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards
- Class 045 — Legal and security services: Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects
Owner
- Advarra, Inc., Columbia, MD, US
- Advarra, Inc., Columbia, MD, US
- Advarra, Inc., Columbia, MD, US
Prosecution history
- 25 Jan 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 20 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Nov 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Oct 2022 — PUBLISHED FOR OPPOSITION
- 14 Sept 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Aug 2022 — EXAMINER'S AMENDMENT ENTERED
- 29 Aug 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Aug 2022 — EXAMINERS AMENDMENT E-MAILED
- 29 Aug 2022 — EXAMINERS AMENDMENT -WRITTEN
- 29 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED